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A mutation in the FAAH gene that enhances endocannabinoid signaling has been difficult to decipher, as it
exists only in humans. A new study reports a knock-in mouse expressing an identical mutation, bridging
an important translational gap.‘‘As little as five years ago,’’ William
Devane recalled, ‘‘most articles
concerning the molecular pharmacology
of cannabinoid drugs began with the
standard refrain ‘the cellular bases of
cannabinoid actions are unknown’’’ [1].
The year was 1994, and Devane
declared a ‘‘New dawn of cannabinoid
pharmacology’’ [1]. Twenty years later,
and many chemical footsteps ahead,
cannabinoid research remains closer to
bench than bedside. In the sociopolitical
climate of 2015, translational research is
held back by fierce debates over
medicinal cannabis legalization.
Clinical studies face two translational
roadblocks: the first is to harness basic
scientific knowledge into production of
new drugs, devices and treatments; the
second is to bring these promising
products to market, and make sure they
actually reach those who need them [2].
Translational research of the cannabinoid
systems, it seems, has passed the
second hurdle before overcoming the
first.
Since California’s Compassionate
Use Act of 1996, over 23 U.S. states and
the District of Columbia have legalized
cannabis for medical use. Yet, the neural
bases of cannabinoid actions in the
human brain are largely unknown
(Figure 1). Understanding the human
cannabinoid system depends heavily onanimal research. Animal models are
the platform for fine-grained molecular
and cellular analysis that is beyond the
reach of human brain science. Still,
many basic findings in animals never
lead to clinical trials. A critical
requirement for successful translation is
that the phenomenon of interest would
have similar phenotypic expression
across species. Satisfying this criterion
has been especially challenging in the
case of the fatty acid amide hydrolase
(FAAH) gene of the endocannabinoid
system. A single-nucleotide
polymorphism in this gene correlates
with anxiety in humans [3]. But a major
obstacle for animal models seeking to
characterize this polymorphism is that
the FAAH variant exists only in the
human brain. A new study by Dincheva
et al. [4] has found a way around it. The
study reports the development of a
knock-in mouse expressing an identical
single-nucleotide mutation of the human
FAAH gene.
In 1988, while in graduate school,
William Devane proved the existence
of the cannabinoid receptor in the rat
brain [5]. By then, the active ingredient
in marijuana that triggers this
receptor, tetrahydrocannabinol (THC),
had been long known – Rapahel
Mechoulam successfully isolated THC
from the cannabis plant in 1964 [6].The missing piece in the puzzle was
the identity of the brain chemical, or
endogenous ligand, that naturally binds
the cannabinoid receptor. Devane
joined Mechoulam’s lab as a postdoc,
to search for the internal equivalent
of the exogenous THC. A few years
later, Devane found the endogenous
ligand [7] and named it ‘anandamide’,
from the Sanskrit word ananda, meaning
‘bliss’.
A blissful function of the
endocannabinoid system is its ability
to relieve pain and anxiety [8]. Perhaps
for that reason alone, several states
have already approved treating post-
traumatic stress disorder (PTSD) with
marijuana and synthetic cannabinoids,
despite the lack of clinical trials
substantiating the medicinal efficacy of
cannabis in PTSD [9]. Studies in animals,
though, do compellingly show that
endocannabinoid manipulations
influence threat learning [10,11]. At the
forefront of PTSD treatment is prolonged
exposure therapy [12]. An animal model
that captures this therapy’s cognitive and
behavioral core is extinction of threat
learning [13]. To mimic a traumatic event
in the laboratory, the animal undergoes
threat conditioning by associating a
neutral stimulus with a negative
outcome; extinction training follows,
where the animal repeatedly encounters2015 Elsevier Ltd All rights reserved R455
Figure 1. Fluid extract from the flowering
tops of Cannabis sativa.
The American Druggists Syndicate Laboratories
manufactured this bottle of liquid cannabis in
1906. The medicinal qualities of cannabis have
been known for thousands of years, and recent
scientific advancements allow scientists to unveil
how cannabinoids work in the human brain.
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Dispatchesthe conditioned stimulus but the negative
outcome is gone. The animal then
exhibits less of the conditioned defensive
responses in the presence of the
no-longer threatening cue [14], a process
relying on neural circuits that often go
awry in PTSD [15].
Animal studies of threat learning have
consistently shown a relationship
between the cannabinoid system and
the ability to extinguish fear, indicating
that drugs that trigger cannabinoid
receptors could potentially aid exposure
therapy in PTSD [9–11]. But such global
pharmacological intervention in
cannabinoid receptor activation may
provoke risky side effects and evenR456 Current Biology 25, R448–R469, June 1opposite results [16]. A more nuanced
approach would be to elevate
endocannabinoid neurotransmitter
availability in the synapse. The beauty
of this approach is that it enhances
anandamide levels only in the specific
regions where it was released [17]. This
is where FAAH comes into play.
FAAH is the catabolic enzyme that
leads to the breakdown and degradation
of anandamide, thereby regulating
anandamide signaling in the brain [17].
About 38 percent of people of European
descent are carriers of the FAAH gene
variant (C385A; AC and AA genotypes)
[18]. In the FAAH single-nucleotide
polymorphism, a threonine (A) residue
substitutes the evolutionarily conserved
proline (C). The mutated FAAH protein
suffers folding abnormalities that render it
more vulnerable to proteolytic
degradation, which in turn rescues
anandamide from degradation [19]. If
carriers of the A-allele gain enhanced
endocannabinoid signaling, would they
better cope with threat?
The road to elucidating the human
endocannabinoid system passes through
the mouse brain, and the knock-in mice
that Dincheva et al. [4] engineered to carry
the FAAH gene variant paved the way.
Human carriers of the A-allele typically
exhibit lower levels of the FAAH protein in
their lymphocytes, but whether parallel
alterations of the endocannabinoid
system in the human brain accompany
these changes in peripheral tissues has
been unclear. Dincheva et al. [4] found
that their knock-in mice expressing the
A-allele had lower FAAH protein levels in
the forebrain, together with increases in
anandamide levels. These findings
validate the FAAH C385A knock-in mice
as a mouse model mirroring the
phenotypic expression of the FAAH
polymorphism in humans.
Dincheva et al. [4] then used this model
to explore higher-level neural and
behavioral processes. They found that
both human and mice carriers of the
A-allele better extinguished conditioned
threat responses, consistent with
previous studies linking the FAAH
polymorphism with individual differences
in reactivity to threat [3]. These findings
imply that the FAAH gene perhaps alters
the neurocircuitry of extinction learning.
The ability to modulate threat learning
relies on the integrity of the ventromedial, 2015 ª2015 Elsevier Ltd All rights reservedprefrontal cortex and its modulatory
connections with the amygdala [20].
Using neuroimaging, Dincheva et al. [4]
indeed found greater resting-state
functional connectivity between the
amygdala and ventromedial prefrontal
cortex in human participants. To delineate
the neuroanatomical connections that
might allow the two regions to
co-activate, Dincheva et al. [4] used their
mouse model to test genotypic
differences in any of the neural tracts
connecting the two regions. They
injected anterograde and retrograde
tracers into the medial prefrontal cortex
of the knock-in mice and revealed an
increase in the projections descending
from the infralimbic region of the
medial prefrontal cortex to the amygdala,
which is the specific pathway that is
critical for extinction learning and
memory [20].
This unique biochemical, neural, and
behavioral signature of A-allele carriers
might explain why some PTSD patients
respond better to exposure therapy and
to certain cannabinoid drugs. Such
findings could steer future therapies
involving the endocannabinoid system
toward a more precise and personally
tailored care. While scientists are laboring
to keep up with legislators, medicinal
cannabis spreads faster than the
narrowing translational gap. But the stride
of discoveries in endocannabinoid
research have opened the door, in the
words of William Devane, to a new dawn
of cannabinoid-based therapy.
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Extensive sequencing of transcriptomes reveals the evolutionary relationships among the major flatworm
lineages, suggesting new roots and conflicting routes to parasitism.Linnaeus had little time for worms, pooling
them with other invertebrates into the
group ‘Vermes’. Beguilingly simple,
vermiform (worm-like) organisms include
some of the most important species
ecologically, evolutionarily, economically
and biomedically. On closer examination,
few vermiform creatures are truly simple,
and many have provided a rich source of
evolutionary novelties sparking major
radiations. The flatworms are particularly
notable (Figure 1). Dorsoventrally
flattened with no body cavity other than a
gut (acoelomate), flatworms have long
been considered simple in body plan and
suitable as a starting point in devising
other more complex animal forms. We
know that other ‘flat worms’ such as
acoels [1] and xenoturbellids [2] have
pivotal, but still controversial, roles in
disentangling the tree of life depending ontheir true position. Originally placed deep
at, or towards, the base of all bilaterally
symmetrical animals, these flattened
worms are now considered more closely
related to echinoderms and vertebrates.
True flatworms (phylum Platyhelminthes)
are nested securely, but not clearly
amongst the Lophotrochozoa [3], a major
grouping amongst the invertebrates. The
disparate positions of flatworms, acoels
and xenoturbellids on the metazoan tree
throws up some weird and wonderful
conundra, such as the origins and
evolution of the anus, the blastopore and
the mouth [4].
With 30,000 described species, and
many more likely to be discovered across
their global range, the Platyhelminthes
reflect a rich source of evolutionary
innovation [5]. Including a plethora of
active aquatic microscopic forms living onand between sand grains, planarians with
remarkable regenerative properties,
multicolored worms found on coral reefs,
the free-living forms are everywhere but
rarely obvious. Flatworms are most
numerous as parasites with simple or
complex life cycles, attaching themselves
on and in other animals. From blood-
dwelling flukes to gut-inhabiting
tapeworms, their success can be
measured in species number, diversity,
biomass or sheer wonderment as to how
they complete their life cycles.
Host-to-host transmission, behavioural
manipulation, fecundity and specificity for
host or even site of infection can each be
astounding. Flatworm parasitism is also
associated with diseases including
debilitating and lethal helminthiases
in humans (schistosomiasis,
echinococcosis, cysticercosis) and2015 Elsevier Ltd All rights reserved R457
